Bend Research Inc. has developed new technology that could increase the lifespan of common influenza vaccines.
Bend Research, working alongside the Seattle-based Path company and Michigan biotechnology company Fraunhofer USA, announced its development of a new spray-drying process, which could make vaccines effective for longer periods of time, according to a joint news release issued Wednesday.
Scientists use a method called spray-drying to prevent vaccines from becoming diluted or insoluble. The process essentially turns a liquid solution into a dry powder-like substance, which maintains its chemical properties for longer periods of time in storage than a liquid solution.
The spray-drying method developed by Bend Research developed an influenza vaccine that remained stable at 50 degrees Celsius for more than two months, according to the release.